Clinical trials for

Nephrotic Syndrome

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-generated · Refreshed daily · Not medical advice.

RecruitingVery early testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingEarly testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingObservational

Ann Arbor, Michigan, United StatesCheck eligibility →

RecruitingObservational

Vienna, AustriaCheck eligibility →

RecruitingSafety & dosing

Los Angeles, California, United States +4 moreCheck eligibility →

RecruitingVery early testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingLarge-scale testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingSafety & dosing

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingObservational

San Francisco, California, United StatesCheck eligibility →

RecruitingInterventional

Atlanta, Georgia, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Anjo, Aichi-ken, Japan +4 moreCheck eligibility →

RecruitingPost-approval study

Al Mansurah, Dakahlia Governorate, EgyptCheck eligibility →

RecruitingLarge-scale testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingObservational

Agen, France +4 moreCheck eligibility →

RecruitingObservational

Bethesda, Maryland, United StatesCheck eligibility →

RecruitingObservational

Chuncheon, South Korea +4 moreCheck eligibility →

RecruitingObservational

Ann Arbor, Michigan, United StatesCheck eligibility →

RecruitingInterventional

Sohag, EgyptCheck eligibility →

RecruitingSafety & dosing

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingInterventional

Dallas, Texas, United StatesCheck eligibility →

AI-generated · Refreshed daily · Not medical advice.

RecruitingVery early testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingEarly testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingObservational

Ann Arbor, Michigan, United StatesCheck eligibility →

RecruitingObservational

Vienna, AustriaCheck eligibility →

RecruitingSafety & dosing

Los Angeles, California, United States +4 moreCheck eligibility →

RecruitingVery early testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingLarge-scale testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingSafety & dosing

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingObservational

San Francisco, California, United StatesCheck eligibility →

RecruitingInterventional

Atlanta, Georgia, United States +4 moreCheck eligibility →

RecruitingLarge-scale testing

Anjo, Aichi-ken, Japan +4 moreCheck eligibility →

RecruitingPost-approval study

Al Mansurah, Dakahlia Governorate, EgyptCheck eligibility →

RecruitingLarge-scale testing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingObservational

Agen, France +4 moreCheck eligibility →

RecruitingObservational

Bethesda, Maryland, United StatesCheck eligibility →

RecruitingObservational

Chuncheon, South Korea +4 moreCheck eligibility →

RecruitingObservational

Ann Arbor, Michigan, United StatesCheck eligibility →

RecruitingInterventional

Sohag, EgyptCheck eligibility →

RecruitingSafety & dosing

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingInterventional

Dallas, Texas, United StatesCheck eligibility →

58 trials · Recruiting

58

Trials actively recruiting patients for Nephrotic Syndrome

Trial status

Phase

Location